Search Results - David M Kent
- Showing 1 - 20 results of 28
- Go to Next Page
-
1
-
2
391 Value estimation of the Diabetes Prevention Program: How well does clinical trial-based cost-effectiveness apply to the real world? by Natalia Olchanski, Samuel B. Weidner, Joshua T. Cohen, David M. Kent
Published in Journal of Clinical and Translational Science (2024-04-01)Get full text
Article -
3
-
4
Estimating individualized treatment effects from randomized controlled trials: a simulation study to compare risk-based approaches by Alexandros Rekkas, Peter R. Rijnbeek, David M. Kent, Ewout W. Steyerberg, David van Klaveren
Published in BMC Medical Research Methodology (2023-03-01)Get full text
Article -
5
-
6
165 Development of science communication rubrics for trainees in clinical and translational science by Angie Mae Rodday, Nicholas Frank, Robert Sege, Robert J Goldberg, Elizabeth Leary, David M Kent, Joshua T Cohen
Published in Journal of Clinical and Translational Science (2025-04-01)Get full text
Article -
7
A standardized framework for risk-based assessment of treatment effect heterogeneity in observational healthcare databases by Alexandros Rekkas, David van Klaveren, Patrick B. Ryan, Ewout W. Steyerberg, David M. Kent, Peter R. Rijnbeek
Published in npj Digital Medicine (2023-03-01)Get full text
Article -
8
Developing a cancer‐specific trigger tool to identify treatment‐related adverse events using administrative data by Saul N. Weingart, Jason Nelson, Benjamin Koethe, Omar Yaghi, Stephan Dunning, Albert Feldman, David M. Kent, Allison Lipitz‐Snyderman
Published in Cancer Medicine (2020-02-01)Get full text
Article -
9
Does poor methodological quality of prediction modeling studies translate to poor model performance? An illustration in traumatic brain injury by Isabel R. A. Retel Helmrich, Ana Mikolić, David M. Kent, Hester F. Lingsma, Laure Wynants, Ewout W. Steyerberg, David van Klaveren
Published in Diagnostic and Prognostic Research (2022-05-01)Get full text
Article -
10
A Clinical Model to Predict the Occurrence of Select High-risk Infections in the First Year Following Heart Transplantation by Whitney A. Perry, MD, MS, Jennifer K. Chow, MD, MS, Jason Nelson, MPH, David M. Kent, MD, MS, David R. Snydman, MD
Published in Transplantation Direct (2023-12-01)Get full text
Article -
11
Statins are rarely prescribed for incidentally discovered covert cerebrovascular disease: a retrospective cohort in a large electronic health record (EHR) identified using natural... by David F Kallmes, David M Kent, Hongfang Liu, Lester Y Leung, Wansu Chen, Eric Puttock, Patrick Luetmer, Sunyang Fu, Chengyi X Zheng
Published in BMJ Neurology Open (2024-11-01)Get full text
Article -
12
-
13
Tufts PACE Clinical Predictive Model Registry: update 1990 through 2015 by Benjamin S. Wessler, Jessica Paulus, Christine M. Lundquist, Muhammad Ajlan, Zuhair Natto, William A. Janes, Nitin Jethmalani, Gowri Raman, Jennifer S. Lutz, David M. Kent
Published in Diagnostic and Prognostic Research (2017-12-01)Get full text
Article -
14
Heterogeneity of Cardiovascular Effects of Second‐Line Glucose‐Lowering Therapies in Adults With Type 2 Diabetes Across the Range of Moderate Baseline Cardiovascular Risk by Yihong Deng, Eric C. Polley, Jeph Herrin, Kavya S. Swarna, David M. Kent, Joseph S. Ross, Bradley A. Maron, Mindy M. Mickelson, Rozalina G. McCoy
Published in Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease (2025-08-01)Get full text
Article -
15
Clinical Prediction Models for Valvular Heart Disease by Benjamin S. Wessler, Christine M. Lundquist, Benjamin Koethe, Jinny G. Park, Kristen Brown, Tatum Williamson, Muhammad Ajlan, Zuhair Natto, Jennifer S. Lutz, Jessica K. Paulus, David M. Kent
Published in Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease (2019-10-01)Get full text
Article -
16
Association of Incidentally Discovered Covert Cerebrovascular Disease Identified Using Natural Language Processing and Future Dementia by David M. Kent, Lester Y. Leung, Yichen Zhou, Patrick H. Luetmer, David F. Kallmes, Jason Nelson, Sunyang Fu, Eric J. Puttock, Chengyi Zheng, Hongfang Liu, Wansu Chen
Published in Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease (2023-01-01)Get full text
Article -
17
Stakeholder engagement in methodological research: Development of a clinical decision support tool by Denise H. Daudelin, Robin Ruthazer, Manlik Kwong, Rebecca C. Lorenzana, Daniel J. Hannon, David M. Kent, Timothy E. McAlindon, Norma Terrin, John B. Wong, Harry P. Selker
Published in Journal of Clinical and Translational Science (2020-04-01)Get full text
Article -
18
Assessment of the impact of EHR heterogeneity for clinical research through a case study of silent brain infarction by Sunyang Fu, Lester Y. Leung, Anne-Olivia Raulli, David F. Kallmes, Kristin A. Kinsman, Kristoff B. Nelson, Michael S. Clark, Patrick H. Luetmer, Paul R. Kingsbury, David M. Kent, Hongfang Liu
Published in BMC Medical Informatics and Decision Making (2020-03-01)Get full text
Article -
19
Treatment effect modification due to comorbidity: Individual participant data meta-analyses of 120 randomised controlled trials by Peter Hanlon, Elaine W. Butterly, Anoop SV Shah, Laurie J. Hannigan, Jim Lewsey, Frances S. Mair, David M. Kent, Bruce Guthrie, Sarah H. Wild, Nicky J. Welton, Sofia Dias, David A. McAllister
Published in PLoS Medicine (2023-06-01)Get full text
Article -
20
Development and validation of self-monitoring auto-updating prognostic models of survival for hospitalized COVID-19 patients by Todd J. Levy, Kevin Coppa, Jinxuan Cang, Douglas P. Barnaby, Marc D. Paradis, Stuart L. Cohen, Alex Makhnevich, David van Klaveren, David M. Kent, Karina W. Davidson, Jamie S. Hirsch, Theodoros P. Zanos
Published in Nature Communications (2022-11-01)Get full text
Article